BioXcel LLC — SEC Form 4 filings

SEC reporting owner CIK 1651990. 1 Form 4 filing on record with FilingPulse; latest filed 2024-06-06.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2024-06-06 to 2024-06-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BioXcel Therapeutics, Inc. (BTAI)10% owner15 legs · 1,427,494 sh · $405,1351

Form 4 filings — BioXcel LLC

FiledFormIssuerReported transactionsSource
2024-06-064BioXcel Therapeutics, Inc. (BTAI)
jointly with Mehta Vimal, BioXcel Holdings, Inc.
Sale (S): 609,221 · Sale (S): 283,123 · Sale (S): 283,122 · Sale (S): 126,014 @ $1.63 · Sale (S): 126,014 @ $1.58 · Sale (S): 120 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1651990 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →